$30.95
-0.92-2.89%
At close: -
$30.95
N/A
After Hours: 4:00 PM EDT
Comments
Loading...
Ultragenyx Pharmaceutical Stock Short Interest Report | NASDAQ:RARE | Benzinga
Short interest in Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) increased during the last reporting period, rising from 7.65M to 8.69M. This put 9.34% of the company's publicly available shares short.
Based on the recent average volume of 1.41M shares traded per day, it would take 6.16 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.
Short Interest
8.69M
Short Interest %
9.34%
Days to Cover
6.16
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc. | 10/15/2025 | 10/24/2025 | 9.34% | 93,071,315 | 8,692,947 | 1,410,509 | 6.16 | |
RARE | Ultragenyx Pharmaceutical Inc. | 09/30/2025 | 10/09/2025 | 8.22% | 93,071,315 | 7,654,589 | 1,965,491 | 3.89 | |
RARE | Ultragenyx Pharmaceutical Inc. | 09/15/2025 | 09/24/2025 | 8.54% | 93,071,315 | 7,947,955 | 1,543,762 | 5.15 | |
RARE | Ultragenyx Pharmaceutical Inc. | 08/29/2025 | 09/10/2025 | 8.94% | 93,071,315 | 8,320,958 | 1,227,310 | 6.78 | |
RARE | Ultragenyx Pharmaceutical Inc. | 08/15/2025 | 08/26/2025 | 9.03% | 93,071,315 | 8,405,280 | 1,733,208 | 4.85 | |
RARE | Ultragenyx Pharmaceutical Inc. | 07/31/2025 | 08/11/2025 | 8.21% | 93,071,315 | 7,638,230 | 2,569,963 | 2.97 | |
RARE | Ultragenyx Pharmaceutical Inc. | 07/15/2025 | 07/24/2025 | 9.65% | 91,241,707 | 8,801,643 | 3,531,858 | 2.49 | |
RARE | Ultragenyx Pharmaceutical Inc. | 06/30/2025 | 07/10/2025 | 7.47% | 91,241,707 | 6,820,252 | 1,007,073 | 6.77 | |
RARE | Ultragenyx Pharmaceutical Inc. | 06/13/2025 | 06/25/2025 | 6.66% | 91,241,707 | 6,081,072 | 1,188,261 | 5.12 | |
RARE | Ultragenyx Pharmaceutical Inc. | 05/30/2025 | 06/10/2025 | 6.08% | 91,241,707 | 5,546,745 | 1,002,669 | 5.53 | |
RARE | Ultragenyx Pharmaceutical Inc. | 05/15/2025 | 05/27/2025 | 6.46% | 91,241,707 | 5,891,832 | 1,033,789 | 5.7 | |
RARE | Ultragenyx Pharmaceutical Inc. | 04/30/2025 | 05/09/2025 | 6.07% | 91,241,707 | 5,535,742 | 884,836 | 6.26 | |
RARE | Ultragenyx Pharmaceutical Inc. | 04/15/2025 | 04/25/2025 | 6.02% | 90,599,339 | 5,456,189 | 1,127,794 | 4.84 | |
RARE | Ultragenyx Pharmaceutical Inc. | 03/31/2025 | 04/09/2025 | 4.99% | 90,599,339 | 4,525,008 | 685,503 | 6.6 | |
RARE | Ultragenyx Pharmaceutical Inc. | 03/14/2025 | 03/25/2025 | 5.97% | 80,660,200 | 4,813,611 | 794,527 | 6.06 | |
RARE | Ultragenyx Pharmaceutical Inc. | 02/28/2025 | 03/11/2025 | 5.69% | 80,660,200 | 4,587,206 | 718,412 | 6.39 | |
RARE | Ultragenyx Pharmaceutical Inc. | 02/14/2025 | 02/26/2025 | 5.31% | 80,660,200 | 4,284,000 | 692,339 | 6.19 | |
RARE | Ultragenyx Pharmaceutical Inc. | 01/31/2025 | 02/11/2025 | 5.17% | 80,503,342 | 4,164,361 | 752,136 | 5.54 | |
RARE | Ultragenyx Pharmaceutical Inc. | 01/15/2025 | 01/27/2025 | 5.28% | 80,503,342 | 4,250,759 | 1,288,898 | 3.3 | |
RARE | Ultragenyx Pharmaceutical Inc. | 12/31/2024 | 01/10/2025 | 4.99% | 80,503,342 | 4,015,892 | 873,761 | 4.6 | |
RARE | Ultragenyx Pharmaceutical Inc. | 12/13/2024 | 12/24/2024 | 4.61% | 80,503,342 | 3,713,992 | 648,542 | 5.73 | |
RARE | Ultragenyx Pharmaceutical Inc. | 11/29/2024 | 12/10/2024 | 4.20% | 80,503,342 | 3,379,045 | 579,980 | 5.83 | |
RARE | Ultragenyx Pharmaceutical Inc. | 11/15/2024 | 11/26/2024 | 4.16% | 80,503,342 | 3,346,228 | 1,139,872 | 2.94 | |
RARE | Ultragenyx Pharmaceutical Inc. | 10/31/2024 | 11/11/2024 | 3.95% | 80,503,342 | 3,179,627 | 556,554 | 5.71 | |
RARE | Ultragenyx Pharmaceutical Inc. | 10/15/2024 | 10/24/2024 | 3.94% | 80,324,264 | 3,164,918 | 688,310 | 4.6 | |
RARE | Ultragenyx Pharmaceutical Inc. | 09/30/2024 | 10/09/2024 | 3.59% | 80,324,264 | 2,887,535 | 602,342 | 4.79 | |
RARE | Ultragenyx Pharmaceutical Inc. | 09/13/2024 | 09/24/2024 | 4.50% | 80,324,264 | 3,614,532 | 576,977 | 6.26 | |
RARE | Ultragenyx Pharmaceutical Inc. | 08/30/2024 | 09/11/2024 | 4.37% | 80,324,264 | 3,509,261 | 681,631 | 5.15 | |
RARE | Ultragenyx Pharmaceutical Inc. | 07/31/2024 | 08/09/2024 | 5.26% | 80,324,264 | 4,226,979 | 644,620 | 6.56 | |
RARE | Ultragenyx Pharmaceutical Inc. | 07/15/2024 | 07/24/2024 | 5.54% | 78,728,313 | 4,362,643 | 760,049 | 5.74 | |
RARE | Ultragenyx Pharmaceutical Inc. | 06/28/2024 | 07/10/2024 | 5.38% | 78,728,313 | 4,235,727 | 1,202,594 | 3.52 | |
RARE | Ultragenyx Pharmaceutical Inc. | 06/14/2024 | 06/26/2024 | 6.40% | 78,728,313 | 5,041,498 | 1,110,094 | 4.54 | |
RARE | Ultragenyx Pharmaceutical Inc. | 05/31/2024 | 06/11/2024 | 6.26% | 71,292,415 | 4,465,450 | 736,533 | 6.06 | |
RARE | Ultragenyx Pharmaceutical Inc. | 05/15/2024 | 05/24/2024 | 6.08% | 71,292,415 | 4,337,729 | 786,393 | 5.52 | |
RARE | Ultragenyx Pharmaceutical Inc. | 04/30/2024 | 05/09/2024 | 6.52% | 71,292,415 | 4,650,347 | 682,037 | 6.82 | |
RARE | Ultragenyx Pharmaceutical Inc. | 04/15/2024 | 04/24/2024 | 6.15% | 71,292,415 | 4,382,486 | 739,361 | 5.93 | |
RARE | Ultragenyx Pharmaceutical Inc. | 03/28/2024 | 04/09/2024 | 4.95% | 79,136,675 | 3,918,427 | 553,110 | 7.08 | |
RARE | Ultragenyx Pharmaceutical Inc. | 03/15/2024 | 03/26/2024 | 4.78% | 79,136,675 | 3,780,931 | 778,413 | 4.86 | |
RARE | Ultragenyx Pharmaceutical Inc. | 02/29/2024 | 03/11/2024 | 4.89% | 79,136,675 | 3,867,566 | 750,922 | 5.15 | |
RARE | Ultragenyx Pharmaceutical Inc. | 02/15/2024 | 02/27/2024 | 4.50% | 79,136,675 | 3,558,020 | 627,599 | 5.67 | |
RARE | Ultragenyx Pharmaceutical Inc. | 01/31/2024 | 02/09/2024 | 4.33% | 78,915,338 | 3,414,342 | 888,900 | 3.84 | |
RARE | Ultragenyx Pharmaceutical Inc. | 01/12/2024 | 01/24/2024 | 5.22% | 78,915,338 | 4,116,209 | 910,678 | 4.52 | |
RARE | Ultragenyx Pharmaceutical Inc. | 12/29/2023 | 01/10/2024 | 5.15% | 78,915,338 | 4,060,198 | 653,448 | 6.21 | |
RARE | Ultragenyx Pharmaceutical Inc. | 12/15/2023 | 12/27/2023 | 4.23% | 78,915,338 | 3,339,794 | 890,577 | 3.75 | |
RARE | Ultragenyx Pharmaceutical Inc. | 11/30/2023 | 12/11/2023 | 4.10% | 78,915,338 | 3,238,184 | 668,693 | 4.84 | |
RARE | Ultragenyx Pharmaceutical Inc. | 11/15/2023 | 11/27/2023 | 4.44% | 78,915,338 | 3,500,936 | 849,772 | 4.12 | |
RARE | Ultragenyx Pharmaceutical Inc. | 10/31/2023 | 11/09/2023 | 5.28% | 78,915,338 | 4,163,945 | 1,733,887 | 2.4 |
Looking for the most shorted stocks?
